36.39MXN
4.78 BMXN
14.08 BMXN
125.67 M
About HALOZYME THERAPEUTICS INC
Sector
Industry
CEO
Helen I. Torley
Website
Headquarters
San Diego
Employees (FY)
373
Founded
1998
ISIN
US40637H1095
FIGI
BBG0125C3CZ4
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where HALO is featured.
Frequently Asked Questions
The current price of HALO is 680.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange HALOZYME THERAPEUTICS INC stocks are traded under the ticker HALO.
HALOZYME THERAPEUTICS INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HALOZYME THERAPEUTICS INC has a max estimate of 1197.55 MXN and a min estimate of 648.67 MXN.
HALO earnings for the last quarter are 13.07 MXN whereas the estimation was 12.31 MXN which accounts for 6.21% surprise. Estimated earnings for the next quarter are 13.56 MXN. See more details about HALOZYME THERAPEUTICS INC earnings.
HALOZYME THERAPEUTICS INC revenue for the last quarter amounts to 3.77 B MXN despite the estimated figure of 3.77 B MXN. In the next quarter revenue is expected to reach 3.92 B MXN.
Yes, you can track HALOZYME THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, HALO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HALOZYME THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 373.00 employees. See our rating of the largest employees — is HALOZYME THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HALOZYME THERAPEUTICS INC EBITDA is 7.17 B MXN, and current EBITDA margin is 50.94%. See more stats in HALOZYME THERAPEUTICS INC financial statements.